# Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
> **Food and Drug Administration** · Final rule. · Published 2011-04-22 · Effective 2011-04-22 · 76 FR 22610
## Document
- **Document number:** 2011-9765
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 76 FR 22610
- **CFR reference:** 21 CFR 522
- **Publication date:** 2011-04-22
- **Effective date:** 2011-04-22
- **HHS docket:** Docket No. FDA-2011-N-0003
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for the addition of a pathogen to the indications for use of enrofloxacin solution in cattle, as a single injection, for the treatment of respiratory disease.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2011/04/22/2011-9765/implantation-or-injectable-dosage-form-new-animal-drugs-enrofloxacin)
---
*AI Analytics · CC0 1.0*